22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here

22nd Century Group is a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology. 

Email Alerts

Stay informed and receive company updates straight to your inbox.

Sign up today